Immunotech Biopharm Ltd

HKEX:6978.HK

2.84 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018
Operating Activities:
Net Income -335.479-321.095-354.615-439.129-109.054-34.888
Depreciation & Amortization 53.39944.07121.00513.78210.9454.513
Deferred Income Tax 0017.7123.739-5.7690
Stock Based Compensation 04.28548.946151.7030.4050.405
Change In Working Capital 12.30845.09419.073-29.3483.305-8.953
Accounts Receivables 000000
Inventory 2.2893.653-6.8910.835-2.519-1.665
Accounts Payables 000000
Other Working Capital 6.63441.44125.964-30.1835.824-7.288
Other Non Cash Items -0.37746.723-6.77215.5884.699-4.751
Operating Cash Flow -163.629-180.922-254.653-263.665-95.469-44.079
Investing Activities:
Investments In Property Plant And Equipment -22.539-96.567-181.239-75.672-21.023-35.07
Acquisitions Net 0000019.588
Purchases Of Investments -100-152.029-150.085-131.9690-50
Sales Maturities Of Investments 0230.0850046.77714.899
Other Investing Activites 2.1741.8923.1183.574-0.0130.183
Investing Cash Flow -116.59723.381-328.206-204.06725.741-50.4
Financing Activities:
Debt Repayment -299-0.017-0.007-0.004-0.003-0.002
Common Stock Issued 0001,137.1110.0030
Common Stock Repurchased 0000-6.8130
Dividends Paid 0000-0.929-33.567
Other Financing Activities -8.519-36.043-10.992-82.419224.951248.014
Financing Cash Flow 273.922-36.06-10.9991,054.688217.209214.447
Other Information:
Effect Of Forex Changes On Cash 0.0170.648-0.127-23.8176.4344.974
Net Change In Cash -6.287-192.953-593.985563.139153.915124.942
Cash At End Of Period 52.16158.448251.401845.386282.247128.332